BANGKOK, April 01, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a technology-driven, diversified growth company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the "SEC").

The annual report can be accessed on the Company's investor relations website at https://investors.newgenivf.com.

About NewGenIVF Group Limited

NewGenIVF Group is a tech-forward, diversified, multi-jurisdictional high-growth entity capitalizing on emerging opportunities across real estate development, digital asset innovation and reproductive health solutions. The Company operates through three strategic business divisions that leverage cutting-edge technology and innovative solutions to drive sustainable growth and high ROI for shareholders across multiple global markets. These include "NewGenProperty", which was established to explore and operate lucrative real estate development projects in the UAE's Ras Al Khaimah Emirate; "NewGenDigital", which serves as the Company's digital asset and DeFi solutions arm; and "NewGenSup", which focuses on health and longevity products and solutions. NewGen's legacy business involves providing industry-leading IVF and assisted reproductive treatment services across Asia. With operations spanning multiple jurisdictions and a commitment to innovative, technology-enabled solutions, NewGenIVF Group is uniquely positioned to capitalize on the convergence of real estate, healthcare and digital asset opportunities in the evolving global economy.

To learn more, visit www.nivf.global. The information contained on, or accessible through, NewGen's website is not incorporated by reference into this press release, and you should not consider it a part of this press release.

Forward-Looking Statements

This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," and similar statements. Without limiting the generality of the foregoing, forward-looking statements in this press release include but are not limited to: statements regarding the Company's business strategy, growth prospects, and operations across its real estate development, digital asset, and reproductive health divisions.

Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. A number of factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the following: the Company's ability to execute its multi-division business strategy; regulatory, legal, and market challenges across the jurisdictions in which the Company operates; competitive pressures in the real estate, digital asset, and healthcare sectors; macroeconomic and geopolitical conditions affecting the Company's markets; and other risks and uncertainties detailed in the Company's annual report on Form 20-F and other filings with the Securities and Exchange Commission.

All information provided in this press release is as of the date of this press release, and NewGen does not undertake any obligation to update any forward-looking statement, except as required under applicable law.

Investor Relations Contact

ICR, LLC

Robin Yang

Phone: +1 (212) 537-4406

Email: Newgenivf.IR@icrinc.com

NewGen Filed 2025 Annual Report on Form 20-F